ORMP logo

Oramed Pharmaceuticals (ORMP) EV/EBITDA

EV/EBITDA

1.84
-0.07-3.66%

91 min ago


Summary


Performance

ORMP EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherORMPvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

ORMP EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-3.7%-3.4%-1.8%
1 m1 month-21.4%-21.3%-12.4%
3 m3 months-12.0%-11.7%-6.5%
6 m6 months+736.4%+729.3%-1.8%
ytdytd-20.0%-19.8%-11.4%
1 y1 year-94.3%-70.8%-23.6%
5 y5 years+126.9%-47.5%-57.3%

ORMP EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-21.4%1.84at low
3 m3-month2.57-28.4%1.79+2.8%
6 m6-month2.57-28.4%0.22+736.4%
1 y1-year38.94-95.3%-0.01>+9999.0%
3 y3-year38.94-95.3%-12.43+114.8%
5 y5-year38.94-95.3%-26.71+106.9%
alltimeall time38.94-95.3%-54.46+103.4%

Oramed Pharmaceuticals EV/EBITDA History

DateValue
2025
1.84(-20.0%)
2024
2.30(-91.8%)
2023
27.95(-346.7%)
2022
-11.33(+67.1%)
2019
-6.78(+115.2%)
2018
-3.15(-72.7%)
2017
-11.53(+43.8%)
2016
-8.02(-35.1%)
DateValue
2015
-12.36(+92.8%)
2014
-6.41(-74.8%)
2013
-25.47(+258.7%)
2012
-7.10(-45.2%)
2011
-12.96(+127.8%)
2010
-5.69(-50.3%)
2009
-11.45(+100.2%)
2008
-5.72

FAQ

  • What is Oramed Pharmaceuticals EV/EBITDA?
  • What is the all time high EV/EBITDA for Oramed Pharmaceuticals?
  • What is ORMP EV/EBITDA year-to-date change?
  • What is Oramed Pharmaceuticals EV/EBITDA year-on-year change?

What is Oramed Pharmaceuticals EV/EBITDA?

The current EV/EBITDA of ORMP is 1.84

What is the all time high EV/EBITDA for Oramed Pharmaceuticals?

Oramed Pharmaceuticals all-time high EV/EBITDA is 38.94

What is ORMP EV/EBITDA year-to-date change?

Oramed Pharmaceuticals EV/EBITDA has changed by -0.46 (-20.00%) since the beginning of the year

What is Oramed Pharmaceuticals EV/EBITDA year-on-year change?

Over the past year, ORMP EV/EBITDA has changed by -30.60 (-94.33%)